Company: MDCXW
Filing Date: 2025-07-30
Form Type: 8-K
Source: 0001062993-25-013266
Chunk: 1

Company: Medicus Pharma Ltd.
Filing Date: 2025-07-30
Form: 8-K
Item: Item 8.01
Chunk 1
---
 to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Readers are cautioned that the foregoing list is not exhaustive, and readers are encouraged to review the Annual Report accessible on the Company's profile on EDGAR atwww. sec. gov and on SEDAR+ at www. sedarplus. ca. Readers are further cautioned not to place undue reliance on forward-looking statements as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

  MEDICUS PHARMA LTD.                                                      
 ───────────────────────────────────────────────────────────────────────────
  By:                      /s/ Raza Bokhari                                
  Name:                    Dr. Raza Bokhari                                
  Title:                   Executive Chairman and Chief Executive Officer  

Dated: July 30, 2025